You are here

Article info

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Varenicline for 4 weeks prior to target quit date reduces prequit date smoking and increases 12-week abstinence

Authors

  1. Correspondence to Gina Daubney Garrison
    Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave, Albany, NY 12208, USA; gina.garrison{at}acphs.edu
View Full Text

Citation

Garrison GD
Varenicline for 4 weeks prior to target quit date reduces prequit date smoking and increases 12-week abstinence
BMJ Evidence-Based Medicine 2012;17:96-97.

Publication history

  • First published December 7, 2011.
Online issue publication 
May 21, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions